Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × dostarlimab × 90 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Colonic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1 Neuroblastoma 1 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer (LARC) 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Brain Neoplasms 1 Bites and Stings 1

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡